Inflammation Research

, Volume 52, Supplement 2, pp S190–S193 | Cite as

Deficiency in reactive oxygen species in p47phox-/-mice attenuates bleomycin induced pulmonary fibrosis

  • B. Manoury
  • O. Leclerc
  • S. Nénan
  • I. Guénon
  • S. Caulet-Maugendre
  • E. Boichot
  • J. M. Planquois
  • C. Bertrand
  • V. Lagente
Young Investigator Award Finalist Mini-Paper 4
  • 31 Downloads

Key word

Reactive oxygen species Pulmonary fibrosis Matrix metalloproteinases 

References

  1. [1]
    Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990; 26: LI59–84.Google Scholar
  2. [2]
    Ward PA, Hunninghake GW. Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998; 157: S123–9.PubMedCrossRefGoogle Scholar
  3. [3]
    Gauldie J, Kolb M, Sime PJ. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res 2002; 3:1.PubMedCrossRefPubMedCentralGoogle Scholar
  4. [4]
    Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor, batismatat. J Pathol 2001; 193(4): 538–45.PubMedCrossRefGoogle Scholar
  5. [5]
    Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, Gauldie J. Differences in the fibrogenic response after transfer of active transforming growth factor-betal gene to lungs of “fibrosis-prone” and “fibrosis-resistant” mouse strains. Am J Respir Cell Mol Biol 2002; 27: 141–50.PubMedCrossRefGoogle Scholar
  6. [6]
    Rahman I, Skwarska E, Henry M, Davis M, O’Connor CM, FitzGerald MX, Greening A, MacNee W. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med 1999; 27: 60–8.PubMedCrossRefGoogle Scholar
  7. [7]
    Jackson SH, Gallin JI, Holland SM. The p47Phox mouse Knock-Out model of chronic granulomatous disease. J Exp Med 1995; 182: 751–758.PubMedCrossRefGoogle Scholar
  8. [8]
    Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29: 225–9.PubMedCrossRefGoogle Scholar
  9. [9]
    Planquois JM, Lec1ere O, Bertrand C. Enhancement of the airway inflammatory response induced by LPS challenge in p47phox knock out (KO) mice. Am J Respir Crit Care Med 2001; 163: A347.Google Scholar
  10. [10]
    Manoury B, Guénon I, Caulet-Maugendre S, Lagente V, Boichot E. Enhanced gelatinase (MMP-2 and MMP-9) activities and TIMP-1 expression in bleomycin-induced pulmonary fibrosis in C57BL/6J and BALB/c mice. Abstract for the 6th World Congress on Inflammation, Vancouver (Canada), August 2003.Google Scholar

Copyright information

© Birkhäuser Verlag, Basel 2003

Authors and Affiliations

  • B. Manoury
    • 1
  • O. Leclerc
    • 2
  • S. Nénan
    • 1
    • 2
  • I. Guénon
    • 1
  • S. Caulet-Maugendre
    • 3
  • E. Boichot
    • 1
  • J. M. Planquois
    • 2
  • C. Bertrand
    • 2
  • V. Lagente
    • 1
  1. 1.INSERM U456RennesFrance
  2. 2.Pfizer Global Research and DevelopmentFresnes LaboratoriesFresnesFrance
  3. 3.Anatomopathologie B, CHU de RennesHôpital de PontchaillouRennesFrance

Personalised recommendations